- KR₩1tn
- KR₩851bn
- KR₩414bn
- 82
- 30
- 80
- 74
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 24.7 | ||
| PEG Ratio (f) | 0.28 | ||
| EPS Growth (f) | 804.76% | ||
| Dividend Yield (f) | 2.99% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.26 | ||
| Price to Tang. Book | 1.31 | ||
| Price to Free Cashflow | 29.55 | ||
| Price to Sales | 2.98 | ||
| EV to EBITDA | 32.1 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -4.26% | ||
| Return on Equity | -2.03% | ||
| Operating Margin | -10.73% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | KR₩m | 1,125,215.55 | 1,370,833.01 | 853,561.09 | 367,375.05 | 414,251.73 | 487,100 | 587,950 | 27.71% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +1830.42 | +7.33 | -65.16 | -99.46 | n/a | n/a | +59.89 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Seegene Inc is a Korea-based company engaged in the development, manufacturing and distribution of molecular diagnostic reagents. The Company mainly provides infectious pathogens inspection products, including allergic respiratory pathogens, sexually transmitted diseases pathogens, human papilloma virus (HPV) and other inspection products, drug resistance inspection products, single nucleotide polymorphisms (SNP) inspection products, as well as somatic mutation cancer inspection products. In addition, it is involved in the provision of automatic real-time detection instruments. The Company provides its products under the brand names of Seeplex, Anyplex and Magicplex. The Company distributes its products within domestic market and to overseas markets.
Directors
- Jin Su Choi PRE (69)
- Jong Yun Cheon CEO (64)
- Beom Jun Kim VPR (56)
- Gi Seon Lee VPR (62)
- Jun Yeong Lee VPR (58)
- Min Cheol Lee VPR (67)
- Jeong Yong Kim MDR (55)
- Dae Yeop Choi MDR (56)
- Seung Gu Kang MDR (53)
- Do Yeon Kim MDR (53)
- Jin Ho Kim MDR (57)
- Won Sik Kim MDR (52)
- Dong Seop Lee MDR (60)
- Bu Hyeon Yang MDR (55)
- Eun Cheol Cho OTH (52)
- Jae Jong Han OTH (51)
- No Jung Huh OTH (73)
- Yin Taek Hwang OTH (49)
- Gyeong Cheol Jang OTH (49)
- Dong Wan Kang OTH (46)
- Seong Yeol Kim OTH (53)
- Dae Hun Lee OTH (49)
- Seong Heon Lee OTH (54)
- Sun Sin Lee OTH (60)
- Yong Rae Lee OTH (55)
- Si Won Noh OTH (48)
- Jun Seok Oh OTH (55)
- Yeong Sang Seo OTH (47)
- Sin Bong Yang OTH (59)
- Seung Hak Yim OTH (53)
- Gyeong Jun Cheon DRC (74)
- Chang Se Lee NID (59)
- Hong Yil Yoon NID (58)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- September 18th, 2000
- Public Since
- September 10th, 2010
- No. of Shareholders
- 121,999
- No. of Employees
- 215
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
Korea Exchange - KOSDAQ- Shares in Issue
- 46,141,943
- Address
- Taewon Bldg., 91, Ogeum-ro, Songpa-gu, SEOUL, 05548
- Web
- https://www.seegene.com/
- Phone
- +82 222404000
- Auditors
- Deloitte Anjin LLC
Upcoming Events for 096530
Q2 2025 Seegene Inc Earnings Release
Similar to 096530
3Billion
Korea Exchange - KOSDAQ
ABion
Korea Exchange - KOSDAQ
ABL Bio
Korea Exchange - KOSDAQ
Amicogen
Korea Exchange - KOSDAQ
AprilBio Co
Korea Exchange - KOSDAQ
FAQ
What is the Seegene share price?
As of Today at 23:09 UTC, shares in Seegene are trading at KR₩26,750. This share price information is delayed by 15 minutes.
How has the Seegene share price performed this year?
Shares in Seegene last closed at KR₩26,750 and the price had moved by +21.69% over the past 365 days. In terms of relative price strength the Seegene share price has outperformed the FTSE Developed Asia Pacific Index by +23.08% over the past year.
What are the analyst and broker recommendations for Seegene?
The overall consensus recommendation for Seegene is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Seegene dividend yield?
The Seegene dividend yield is 2.99% based on the trailing twelve month period.
Does Seegene pay a dividend?
Last year, Seegene paid a total dividend of KR₩800, and it currently has a trailing dividend yield of 2.99%. We do not have any data on when Seegene is to next pay dividends.
When does Seegene next pay dividends?
We do not have data on when Seegene is to next pay dividends. The historic dividend yield on Seegene shares is currently 2.99%.
How do I buy Seegene shares?
To buy shares in Seegene you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Seegene?
As of the previous close price of KR₩26,750, shares in Seegene had a market capitalisation of KR₩1tn.
Where are Seegene shares listed?
Here are the trading details for Seegene:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 096530
What kind of share is Seegene?
Based on an overall assessment of its quality, value and momentum Seegene is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Seegene share price forecast for 2025?
The analyst consensus target price for shares in Seegene is KR₩38,214. That is 42.86% above the last closing price of KR₩26,750.
Analysts covering Seegene currently have a consensus Earnings Per Share (EPS) forecast of KR₩910 for the next financial year.
Find out moreWhat is the trend in the Seegene share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Seegene. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +24.4%.
As of the last closing price of KR₩26,750, shares in Seegene were trading +11.44% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Seegene PE Ratio?
The Seegene PE ratio based on its reported earnings over the past 12 months is 24.7. The shares last closed at KR₩26,750.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Seegene?
Seegene's management team is headed by:
- Jin Su Choi - PRE
- Jong Yun Cheon - CEO
- Beom Jun Kim - VPR
- Gi Seon Lee - VPR
- Jun Yeong Lee - VPR
- Min Cheol Lee - VPR
- Jeong Yong Kim - MDR
- Dae Yeop Choi - MDR
- Seung Gu Kang - MDR
- Do Yeon Kim - MDR
- Jin Ho Kim - MDR
- Won Sik Kim - MDR
- Dong Seop Lee - MDR
- Bu Hyeon Yang - MDR
- Eun Cheol Cho - OTH
- Jae Jong Han - OTH
- No Jung Huh - OTH
- Yin Taek Hwang - OTH
- Gyeong Cheol Jang - OTH
- Dong Wan Kang - OTH
- Seong Yeol Kim - OTH
- Dae Hun Lee - OTH
- Seong Heon Lee - OTH
- Sun Sin Lee - OTH
- Yong Rae Lee - OTH
- Si Won Noh - OTH
- Jun Seok Oh - OTH
- Yeong Sang Seo - OTH
- Sin Bong Yang - OTH
- Seung Hak Yim - OTH
- Gyeong Jun Cheon - DRC
- Chang Se Lee - NID
- Hong Yil Yoon - NID